Joseph Villanacci
Rheumatology · San Antonio, TXNPI 1609373810
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 108 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 23.1% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,486, 8.8 times the $170 reported in 2023. That places this record below the midpoint for rheumatology clinicians in TX, where the typical reported total is $3,779.
Across 108 payments — averaging $25.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$647
- ANI Pharmaceuticals, Inc.$424
- Amgen$350
- Novartis$243
- Livanova USA, Inc.$184
- AstraZeneca$168
- plus $784 from 15 others
What the payments were for
- Food & beverage$2,800100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 28 | $647 |
| ANI Pharmaceuticals, Inc. | 8 | $424 |
| Amgen | 9 | $350 |
| Novartis | 11 | $243 |
| Livanova USA, Inc. | 9 | $184 |
| AstraZeneca(2 entities) | 8 | $168 |
| UCB, Inc. | 5 | $161 |
| GSK | 5 | $112 |
| Teva Pharmaceuticals USA, Inc. | 5 | $100 |
| EMD Serono, Inc. | 3 | $68 |
| Johnson & Johnson | 3 | $67 |
| Argenx US, Inc. | 2 | $49 |
| Octapharma USA, Inc. | 2 | $39 |
| Biogen | 2 | $38 |
| E.r. Squibb & Sons, L.L.C. | 2 | $35 |
| Neurelis, Inc. | 1 | $32 |
| Vanda Pharmaceuticals Inc. | 1 | $20 |
| Catalyst Pharmaceuticals, Inc. | 1 | $19 |
| Medtronic | 1 | $17 |
| Sandoz | 1 | $15 |
| Tonix Medicines, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PURIFIED CORTROPHIN GEL$343
- Otezla$250
- Rinvoq$246
How this compares
$2,800 in reported general payments places this provider in the 45th percentile of 512 rheumatology providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira PenAdalimumab | 24 | $305,590 |
| Enbrel SureclickEtanercept | 33 | $259,233 |
| Humira(Cf) PenAdalimumab | 19 | $133,128 |
| Actemra ActpenTocilizumab | 14 | $80,722 |
| Hydroxychloroquine Sulfate | 56 | $1,880 |
| MethotrexateMethotrexate Sodium | 68 | $954 |
| Leflunomide | 16 | $553 |
| Sulfasalazine | 13 | $456 |
| Prednisone | 68 | $434 |
| Folic Acid | 19 | $140 |
Paid to pharmacies, not to this prescriber.
Other rheumatology in San Antonio
- Pendleton WickershamSan Antonio$954K
- Thomas RennieSan Antonio$113K
- Kevin KempfSan Antonio$83K
- Alex DejesusSan Antonio$68K
- Jane AyalaSan Antonio$67K
- Pankhuri GuptaSan Antonio$58K
- Fernando SilvaSan Antonio$54K
- John CushDallas$3.7M
- Sanjay ChabraEl Paso$3.3M
- Dhiman BasuColleyville$1.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.